ProQR (PRQR) Surges Amid Positive 1/2 trial of QR-110, Plans to Progress to Pivotal Phase 2/3 Trial
ProQR (NASDAQ: PRQR) surges 64% after the company announced results from a planned interim ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
